alexion pharmaceuticals inc
(ALXN:Consolidated Issue Listed on NASDAQ Global Select )
Transactions by ALEXION PHARMACEUTICALS INC (ALXN) in the last 6 months
Moderna LLC announced that it will receive $502,168,634 in funding on December 19, 2014. The company will issue series E preferred units in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
As of January 5, 2015, the company received $446,069,409 from 43 investors including new investors Viking Global Investors LP, Invus, RA Capital Management, and Wellington Management Company, LLP. The transaction included participation ...
RA Capital Management, LLC
The Invus Group, LLC
Viking Global Investors L.P.
Wellington Management Company LLP
Alexion Pharmaceuticals, Inc. (NasdaqGS:ALXN) announces a share repurchase program. Under the program, the company will repurchase up to $500 million of its common stock. The repurchases will be made from time to time on the open market, including through 10b5-1 trading plans, or through privately negotiated transactions, block transactions, or other techniques. The company expects to fund all purchases from cash on hand and future cash flows from operations. Repurchases ...
|Dr Reddy's Laboratories Ltd||3,484 INR||-44.65|
|Pharmacyclics Inc||$256.59 USD||-0.51|
|Sigma-Aldrich Corp||$139.00 USD||+0.03|
|Symrise AG||€57.16 EUR||-0.157|
|United Therapeutics Corp||$186.69 USD||-1.87|
|View Industry Companies|